Mechanisms of Brain Hypoperfusion in AD/ADRD (R01 Clinical Trial Not Allowed)
Department of Health and Human Services National Institutes of Health
Posted on:
Application Deadline:
Expired
Type
Research/project funding
Reference Number
RFA-AG-23-014
This Funding Opportunity Announcement (FOA) solicits applications for projects designed to understand molecular and cellular mechanisms underlying cerebral blood flow reduction in Alzheimers disease (AD) and Alzheimers disease-related dementias (ADRD).
Categories: Health.
Categories: Health.
United States